Safety, Pharmacokinetics, and Sex Hormone Suppression of LY01021 versus Relugolix: A Single- and Multiple-Dose Escalation Study.
LY01021 is a novel oral small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of various sex hormone-dependent disorders. This study aimed to evaluate the safety, tolerability, pharmacokinetics (PK), …
Sky Sports presenter shares health update with fans after undergoing surgery and opens up on 'heartbreaking' condition that 'isn't spoken about enough' - MSN
Sky Sports presenter shares health update with fans after undergoing surgery and opens up on 'heartbreaking' condition that 'isn't spoken about enough' MSN